Hila Elinav

1.0k total citations
42 papers, 484 citations indexed

About

Hila Elinav is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Hila Elinav has authored 42 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 16 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Hila Elinav's work include HIV/AIDS Research and Interventions (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (6 papers). Hila Elinav is often cited by papers focused on HIV/AIDS Research and Interventions (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (6 papers). Hila Elinav collaborates with scholars based in Israel, United States and Germany. Hila Elinav's co-authors include Gili Zilberman-Schapira, Niv Zmora, Eran Elinav, Stavros Bashiardes, Ran Nir‐Paz, Yaron Ilan, Meir Shalit, Maya Margalit, Itzhack Polacheck and Shmuel Benenson and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Hila Elinav

36 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hila Elinav Israel 13 214 200 93 56 54 42 484
Mário León Silva-Vergara Brazil 14 192 0.9× 369 1.8× 35 0.4× 57 1.0× 32 0.6× 38 576
Howard M. Heller United States 11 193 0.9× 169 0.8× 70 0.8× 66 1.2× 35 0.6× 22 629
Mario Perotti Italy 14 76 0.4× 290 1.4× 81 0.9× 26 0.5× 27 0.5× 29 605
Quanhathai Kaewpoowat United States 9 125 0.6× 229 1.1× 43 0.5× 8 0.1× 66 1.2× 31 425
Antonio Chuh Hong Kong 19 288 1.3× 458 2.3× 21 0.2× 62 1.1× 29 0.5× 85 1.0k
Luz Orozco‐Covarrubias Mexico 13 109 0.5× 100 0.5× 49 0.5× 32 0.6× 103 1.9× 38 583
J. Robert Burge United States 17 61 0.3× 179 0.9× 115 1.2× 32 0.6× 174 3.2× 26 769
David Hassin Israel 15 152 0.7× 261 1.3× 118 1.3× 8 0.1× 109 2.0× 31 657
Lars M. Koenig Germany 11 219 1.0× 95 0.5× 374 4.0× 19 0.3× 34 0.6× 12 619
Joseph Taboada United States 15 163 0.8× 136 0.7× 40 0.4× 9 0.2× 75 1.4× 37 610

Countries citing papers authored by Hila Elinav

Since Specialization
Citations

This map shows the geographic impact of Hila Elinav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hila Elinav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hila Elinav more than expected).

Fields of papers citing papers by Hila Elinav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hila Elinav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hila Elinav. The network helps show where Hila Elinav may publish in the future.

Co-authorship network of co-authors of Hila Elinav

This figure shows the co-authorship network connecting the top 25 collaborators of Hila Elinav. A scholar is included among the top collaborators of Hila Elinav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hila Elinav. Hila Elinav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cahn, Avivit, Valery Istomin, Sarah Israel, et al.. (2024). Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters. The Journal of Infectious Diseases. 230(2). 411–420. 2 indexed citations
3.
Ahmad, Wiessam Abu, et al.. (2024). The effect of a treatment switch to integrase Strand transfer inhibitor–based regimens on weight gain and other metabolic syndrome-related conditions. BMC Infectious Diseases. 24(1). 221–221. 1 indexed citations
4.
Rozen, Guy, Maya Korem, Hila Elinav, et al.. (2023). The Relationship between Body Mass Index and In-Hospital Mortality in Bacteremic Sepsis. Journal of Clinical Medicine. 12(11). 3848–3848. 7 indexed citations
6.
Levy, Itzchak, Daniel Elbirt, Eduardo Shahar, et al.. (2023). Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in Israel. Viruses. 15(12). 2439–2439. 4 indexed citations
7.
Elinav, Hila, et al.. (2022). Images of the month 2: Disseminated nocardiosis in a 60-year-old woman with sarcoidosis. Clinical Medicine. 22(2). 165–165.
8.
Elinav, Hila, et al.. (2021). Endophthalmitis panorama in the Jerusalem area. International Ophthalmology. 42(5). 1523–1535. 2 indexed citations
9.
Turner, Dan, Itzchak Levy, Daniel Elbirt, et al.. (2021). Long term dual antiretroviral therapy: A real life retrospective countrywide Israeli study. PLoS ONE. 16(10). e0259271–e0259271. 1 indexed citations
10.
Israel, Sarah, Hila Elinav, Ram Elazary, et al.. (2020). Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy. Antimicrobial Agents and Chemotherapy. 64(4). 14 indexed citations
11.
Chowers, Michal, Daniel Chemtob, Orna Mor, et al.. (2020). Continuum of HIV care of newly diagnosed individuals in Israel, 2011–2015: a population-based cohort study. International Journal of STD & AIDS. 31(4). 326–334. 1 indexed citations
12.
Stein, Merle, Maayan Barnea, Moran Shalev, et al.. (2020). Massive osteopetrosis caused by non-functional osteoclasts in R51Q SNX10 mutant mice. Bone. 136. 115360–115360. 9 indexed citations
13.
Levine, Hagai, et al.. (2020). Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?. Israel Journal of Health Policy Research. 9(1). 10–10. 2 indexed citations
14.
Elinav, Hila, et al.. (2019). Malignant deep brain stimulator withdrawal syndrome. BMJ Case Reports. 12(5). e229122–e229122. 19 indexed citations
15.
Elinav, Hila, et al.. (2017). Breast Implant Q Fever as a Source of In-Hospital Transmission. Clinical Infectious Diseases. 66(5). 793–795. 1 indexed citations
16.
Khoury, Tawfik, et al.. (2015). Familial Q fever clustering with variable manifestations imitating infectious and autoimmune disease. Clinical Microbiology and Infection. 21(5). 459–463. 5 indexed citations
17.
Ben‐Chetrit, Eli, Yonit Wiener‐Well, Lester M. Shulman, et al.. (2014). Coxsackievirus A6-related hand foot and mouth disease: Skin manifestations in a cluster of adult patients. Journal of Clinical Virology. 59(3). 201–203. 37 indexed citations
18.
Ben‐Ami, Ronen, Galia Rahav, Hila Elinav, et al.. (2012). Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel. Clinical Microbiology and Infection. 19(8). 752–756. 19 indexed citations
19.
Elinav, Hila, et al.. (2011). HIV/AIDS among Palestinians: detection, clinical presentation, prognosis and HIV testing patterns, 1994–2010. International Journal of Infectious Diseases. 15(6). e377–e381. 2 indexed citations
20.
Elinav, Hila, et al.. (2009). Rhinocerebral mucormycosis in patients without predisposing medical conditions: a review of the literature. Clinical Microbiology and Infection. 15(7). 693–697. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026